Tebentafusptebentafusp-associatedmetastatic uveal melanoma
… Published online 2025 Jun 12.Tomsitz D, Ruf T, Heppt M, et al. Tebentafusp in patients with metastatic uveal melanoma: a real-life retrosp…
7articles mentioning drugs
24drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tebentafusp ×
tebentafusp
This drug is selected. Its supporting articles are shown below.
Articles mentioning tebentafusp
7 articles · page 1 of 1tebentafusptebentafusp-treatedImmTACuveal melanomamUMNCT02570308
…biopsies, infiltrating CD3 + T cells increased after 3 doses of tebentafusp, more so in TCF high patients (3.4 fold change [FC]) compared t…
tarlatamabtebentafuspsolid tumorsovarian carcinomas
…n solid tumors as evidenced by the approvals of tebentafusp and tarlatamab. Despite these initial clinical successes, there remains a pauc…
tebentafuspafamitresgene autoleucelDARKFOX-A3solid tumorsesophageal adenocarcinomaTargeted immunotherapiesovarian carcinomas
…gy for solid tumors, exemplified by the recent FDA approvals of tebentafusp and afamitresgene autoleucel, which target Class I peptide-HLA …
MAGE-A196-104gp10017-25afamiceltebentafuspMAGE-A4NCT01585350
…ed HLA-A*03:01-restricted TCRs for the peptides gp100 17-25 and MAGE-A196-104 were isolated from peripheral blood after vaccination. Multiple…
tebentafuspTCEscancers
…cell killing efficacy to clinically validated molecules such as tebentafusp.Conclusions In this work, we showcase the discovery and enginee…
TarlatamabVIB193CatumaxomabTebentafuspLUSCPAADLUADCHOLKIRCsolid tumors+1 more
…itional drugs: the TCR-based Tebentafusp and the antibody-based Tarlatamab. The limited progress in this field is largely attributed to ch…